Related references
Note: Only part of the references are listed.Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib
Y. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer
Masaki Tomita et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
M. Grunnet et al.
LUNG CANCER (2012)
Biomarkers in the Lung Cancer Diagnosis: A Clinical Perspective
X. Li et al.
NEOPLASMA (2012)
Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer
Marina Petrovic et al.
BIOMARKERS (2011)
The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited
Shaohua Ma et al.
CANCER BIOMARKERS (2011)
Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC)
Susana Cedres et al.
CLINICAL LUNG CANCER (2011)
Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer
Vivian Barak et al.
CANCER BIOMARKERS (2010)
Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer
Stefan Holdenrieder et al.
CANCER BIOMARKERS (2010)
Increased Serum CA-125 Levels in Patients with Lung Cancer Post Thoracotomy
Geila Ribeiro Nunez et al.
SOUTHERN MEDICAL JOURNAL (2009)
Locally advanced non-small cell lung cancer: The past, present, and future
Ramaswamy Govindan et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer
Katsunori Kagohashi et al.
MEDICAL ONCOLOGY (2008)
Serum Sialyl Lewisx and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer
Shinjiro Mizuguchi et al.
LUNG CANCER (2007)
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer
William Chi-Shing Cho
BIOMEDICINE & PHARMACOTHERAPY (2007)
Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib
Chao-Hua Chiu et al.
LUNG CANCER (2007)
The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer
B Nisman et al.
TUMOR BIOLOGY (2006)
New tumor markers: CA125 and beyond
RC Bast et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Pathogenesis of lung cancer - 100 year report
YE Miller
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer
F Barlési et al.
RESPIRATORY MEDICINE (2004)
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
JL Pujol et al.
LUNG CANCER (2003)
Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
N Reinmuth et al.
LUNG CANCER (2002)
Prognostic value of serum tumor markers in patients with lung cancer
KD Hatzakis et al.
RESPIRATION (2002)
Brain metastases at the time of presentation of nonsmall cell lung cancer: a multi-centric AERIO* analysis of prognostic factors
W Jacot et al.
BRITISH JOURNAL OF CANCER (2001)
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients
JL Pujol et al.
LUNG CANCER (2001)
Share Paper
